相关实验视频

Updated: Apr 10, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

在PLO凝MedifloTM30预混合中对美西马USP的括号稳定性评估

Anh Tran¹, Kathryn Hunt², Claude Bernal¹

¹CED Analytical Labs, Irving, Texas, United States.

International journal of pharmaceutical compounding

|May 20, 2024

概括

复合甲基马 1% 和 10% 凝表现出优异的物理,化学和微生物稳定性. 这些发现支持梅西马凝配方的使用期限延长120天.

科学领域:

制药复合物制药复合物
药物稳定性研究药物稳定性研究
皮肤学配方皮肤学配方

背景情况:

药物的随时组合对于个性化患者治疗至关重要.
甲基马是一种重要的抗甲状腺剂,需要稳定的配方才能有效使用.
复合制剂的稳定性评估确保了治疗疗效和患者安全.

研究的目的:

评估PLO凝中临时化合物甲基马1%和10%的物理,化学和微生物稳定性.
为了确定这些梅西马凝配方的适当的过期日期.
确保复合甲基马制剂的质量和安全性.

主要方法:

在PLO凝中制备了甲基马1%和10%的配方.
稳定性测试包括感官外观,pH值测量和高性能液态染色学 (HPLC) 分析.
根据美国药典 (USP) <51>指南评估了抗菌药物的有效性.
样品被储存在室温的耐光容器中.

主要成果:

在整个研究期间,复合甲基马1%和10%凝保持在既定的稳定性标准范围内.
在经过测试的储存条件下,没有观察到显著的降解或物理变化.
抗菌有效性测试证实了配方的完整性.

结论:

在PLO凝中提前组合的甲基马1%和10%表现出良好的稳定性.
这些配方在特定的储存条件下可以延长120天的使用期限.
这些发现为药剂师组合甲基马制剂提供了有价值的数据.

更多相关视频

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Microfluidic Synthesis of Microgel Building Blocks for Microporous Annealed Particle Scaffold

Microfluidic Synthesis of Microgel Building Blocks for Microporous Annealed Particle Scaffold

Published on: June 16, 2022

相关概念视频

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...